Letermovir market reference price and purchase channel description in 2025

Letermovir is currently on the market in China and is mainly used to prevent cytomegalovirus (CMV) infection after transplantation, especially in stem cell transplant patients. The drug is available in tablet and injection forms in the country and is suitable for different clinical use needs. Tablets are suitable for outpatient oral treatment, while injections are suitable for hospitalized intravenous infusion or patients who cannot take oral medications. Clinical use is flexible and it is easy to choose dosage forms according to patient conditions.

In the domestic market, the price of letermovir tablets is relatively high, with a box usually selling for tens of thousands of yuan, while the price of injections is relatively low, about five to six hundred yuan. Specific prices may vary by region, hospital or pharmacy, so patients should refer to the real-time quotes from local pharmacies when purchasing. Since drugs are included in medical insurance, eligible patients can be reimbursed for part of the cost through medical insurance, thus reducing their financial burden.

In overseas markets, generic drugs of Letermovir are also available, and the prices are generally lower than those of the original drugs. For example, a box of tablets produced by Lucius in Laos costs about 2,000 yuan. For domestic patients who are temporarily unable to purchase drugs through formal channels, some obtain drugs through overseas legal channels, but attention must be paid to drug transportation, storage conditions and import compliance to ensure drug safety.

In terms of purchase channels, domestic patients should give priority to obtaining Letermovir through regular hospitals and pharmacies, purchase it with a prescription and use it as directed by the doctor. Both tablets and injections must be used under the guidance of a doctor to ensure efficacy and safety. Overseas drugs are only used as temporary supplements or for special needs. Patients should fully communicate with professional doctors before use and avoid purchasing drugs through informal channels to ensure treatment safety and legal compliance.

Reference:https://reference.medscape.com/